BlackRock Health Sciences Trust II (BMEZ)vsBlackstone Group Inc (BX)
BMEZ
BlackRock Health Sciences Trust II
$17.29
-1.26%
FINANCIAL SERVICES · Cap: $1.10B
BX
Blackstone Group Inc
$118.53
-2.84%
FINANCIAL SERVICES · Cap: $141.65B
Smart Verdict
WallStSmart Research — data-driven comparison
BX leads profitability with a 23.0% profit margin vs 0.0%. BMEZ trades at a lower P/E of 5.2x. BX earns a higher WallStSmart Score of 59/100 (C).
BMEZ
Avoid30
out of 100
Grade: F
BX
Buy59
out of 100
Grade: C
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Conservative balance sheet, low leverage
Every $100 of equity generates 40 in profit
Strong operational efficiency at 48.9%
Large-cap with strong market position
Keeps 23 of every $100 in revenue as profit
Generating 1.9B in free cash flow
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 5.7% — below average capital efficiency
Moderate valuation
Trading at 10.7x book value
3.7% earnings growth
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : BMEZ
The strongest argument for BMEZ centers on P/E Ratio, Debt/Equity.
Bull Case : BX
The strongest argument for BX centers on Return on Equity, Operating Margin, Market Cap. Profitability is solid with margins at 23.0% and operating margin at 48.9%. PEG of 1.17 suggests the stock is reasonably priced for its growth.
Bear Case : BMEZ
The primary concerns for BMEZ are Revenue Growth, EPS Growth, Market Cap.
Bear Case : BX
The primary concerns for BX are P/E Ratio, Price/Book, EPS Growth. Debt-to-equity of 1.61 is elevated, increasing financial risk.
Key Dynamics to Monitor
BMEZ profiles as a value stock while BX is a declining play — different risk/reward profiles.
BMEZ is growing revenue faster at 0.0% — sustainability is the question.
BX generates stronger free cash flow (1.9B), providing more financial flexibility.
Monitor ASSET MANAGEMENT industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BX scores higher overall (59/100 vs 30/100), backed by strong 23.0% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
BlackRock Health Sciences Trust II
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
BlackRock Health Sciences Trust II (BMEZ) is a closed-end fund that focuses on delivering high total returns through a diversified portfolio primarily concentrated in the health sciences sector, which encompasses pharmaceuticals, biotechnology, and medical devices. Capitalizing on BlackRock's extensive industry knowledge, BMEZ targets significant growth opportunities driven by demographic shifts and increasing healthcare spending. With its disciplined investment approach and commitment to funding innovative healthcare solutions, BMEZ provides institutional investors a compelling avenue for portfolio enhancement in a dynamic and rapidly evolving market landscape.
Blackstone Group Inc
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
Blackstone Group Inc. is an alternative asset management company specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity strategies and multiple asset classes. The company is headquartered in New York, New York with additional offices across Asia, Europe and North America.
Compare with Other ASSET MANAGEMENT Stocks
Want to dig deeper into these stocks?